Randomized Phase III Study of Pegylated Liposomal Doxorubicin Plus Bortezomib Compared With Bortezomib Alone in Relapsed or Refractory Multiple Myeloma: Combination Therapy Improves Time to ...
Positron Emission Tomography–Positive Post-Chemotherapy Seminoma Masses: Time to Reevaluate the Role of Radiotherapy? The following represents disclosure information provided by authors of this ...
Contineum Therapeutics, Inc. (NASDAQ: CTNM) (Contineum or the Company), a clinical-stage biopharmaceutical company pioneering differentiated therapies for the treatment of neuroscience, inflammation ...
- PIPE-791 achieved high LPA1 brain receptor occupancy (RO) in healthy volunteers and progressive multiple sclerosis (PrMS) patients - PIPE-791 showed a safety and tolerability profile consistent with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results